 |
 Video: What is a Stock Split?
|
|
|
| Citius Pharmaceuticals is a pharmaceutical company. Co. is developing the following products: Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a IL-2 diphtheria toxin fusion protein for the treatment of patients with recurrent cutaneous T-cell lymphoma. According to our Citius Pharmaceuticals stock split history records, Citius Pharmaceuticals has had 0 splits. | |
|
Citius Pharmaceuticals (CTXR) has 0 splits in our Citius Pharmaceuticals stock split history database.
Looking at the Citius Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Citius Pharmaceuticals shares, starting with a $10,000 purchase of CTXR, presented on a split-history-adjusted basis factoring in the complete Citius Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/13/2017 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$6.60 |
|
| End price/share: |
$0.72 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-89.14% |
|
| Average Annual Total Return: |
-27.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,085.90 |
|
| Years: |
6.87 |
|
|
|
|
|
